<DOC>
	<DOCNO>NCT00691314</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety stent implantation patient symptomatic extra- intracranial artery stenosis determine role secondary prevention ischemic stroke .</brief_summary>
	<brief_title>Efficacy Safety Stent Implantation Symptomatic Extra- Intracranial Artery Stenosis</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Ischemic Attack , Transient</mesh_term>
	<criteria>1 . Aged 40 yearold 75 yearold . 2 . Ischemic stroke related extra intracranial atherosclerosis stenosis , transient ischemic attack ( TIA ) , onset time within 90 day 3 . Implantation stent least 1 week stroke onset , patient 's medical condition stable , time limit TIA , 4 . Stenosed ICA MCA BA VA candidate artery stent implantation . 5 . Degree stenosis target artery range 51 % 99 % 6 . Modified Rankin score≤3 NIHSS Score ≤4 7 . Informed consent obtain . Patients exclude entry criterion list meet : 1 . Target stenosis artery suitable stent implantation evaluation . 2 . Previous carotid endarterectomy carotid artery stent , intracranial artery stent implantation . 3 . Ischemic stroke cause condition atherosclerosis . 4 . Documented nonatherosclerosis angiopathy . 5 . Clinically unstable time enrollment , 6 . Conditions may lead cardiogenic embolism : arterial fibrillation，left ventricular thrombus , Myocardiac infarction within 6 week , etc . 7 . Severe hypertension ( systolic blood pressure &gt; 180 mmHg diastolic blood pressure &gt; 110 mmHg ) 8 . Severe comorbid unstable medical condition , ie，severe heart failure , pulmonary failure renal failure , liver dysfunction ( serum liver enzyme twice normal level ) , malignancy likelihood death within next 2 year 9 . Significant memory behavioral disorder , ie , Alzheimer disease , etc.daily care need . 10 . Concurrent participation another clinical trial 11 . Unable return follow 12 . History hemorrhagic disease ( ie , intracranial hemorrhage , Idiopathic Thrombocytopenic Purpura , etc ) bleeding tendency condition . 13 . Intracranial arteriovenous malformation aneurysm .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Stroke</keyword>
	<keyword>Transietn Ischemic Attack</keyword>
	<keyword>Stents</keyword>
	<keyword>Stenosis</keyword>
</DOC>